Zhejiang CONBA Pharmaceutical Co.,Ltd. — Investor Relations & Filings
Zhejiang CONBA Pharmaceutical Co.,Ltd. specializes in the research, development, manufacturing, and marketing of a diverse range of pharmaceutical products, with a primary focus on modern Chinese medicine and chemical drugs. The company's portfolio encompasses therapeutic areas such as cardiovascular health, digestive systems, respiratory care, and urology. Notable products include its proprietary pollen preparations for prostate health and high-purity Ginkgo biloba extracts. CONBA integrates traditional botanical knowledge with advanced extraction and formulation technologies to produce standardized health solutions. Its operations span the entire value chain, including medicinal plant cultivation, active pharmaceutical ingredient production, and finished dosage manufacturing. The company serves both clinical and over-the-counter markets, emphasizing quality control and innovation in botanical medicine.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公司2025年年度股东会决议公告 | 2026-05-13 | Chinese | |
| 公司第十一届董事会第十六次会议决议公告 | 2026-04-22 | Chinese | |
| 会计师事务所对公司内部控制的审计报告 | 2026-04-22 | Chinese | |
| 康恩贝2025年内部控制评价报告 | 2026-04-22 | Chinese | |
| 关于公司2026年度银行综合授信及融资相关事项授权的公告 | 2026-04-22 | Chinese | |
| 康恩贝2025年环境、社会和公司治理报告摘要 | 2026-04-22 | Chinese |
Browse filings by year
23 years- 2026 39 filings
- 2025 128 filings
- 2024 126 filings
- 2023 131 filings
- 2022 138 filings
- 2021 158 filings
- 2020 198 filings
- 2019 206 filings
- 2018 221 filings
- 2017 115 filings
- 2016 205 filings
- 2015 224 filings
- 2014 161 filings
- 2013 92 filings
- 2012 108 filings
- 2011 82 filings
- 2010 61 filings
- 2009 74 filings
- 2008 57 filings
- 2007 90 filings
- 2006 52 filings
- 2005 71 filings
- 2004 49 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45774155 | 公司2025年年度股东会决议公告 | 2026-05-13 | Chinese | ||
| 41177435 | 公司第十一届董事会第十六次会议决议公告 | 2026-04-22 | Chinese | ||
| 41177431 | 会计师事务所对公司内部控制的审计报告 | 2026-04-22 | Chinese | ||
| 41177428 | 康恩贝2025年内部控制评价报告 | 2026-04-22 | Chinese | ||
| 41177425 | 关于公司2026年度银行综合授信及融资相关事项授权的公告 | 2026-04-22 | Chinese | ||
| 41177423 | 康恩贝2025年环境、社会和公司治理报告摘要 | 2026-04-22 | Chinese | ||
| 41177421 | 康恩贝2025年度“提质增效重回报”行动方案评估报告暨2026年度“提质增效重回报”行动方案 | 2026-04-22 | Chinese | ||
| 41177419 | 独立董事2025年度述职报告（曾苏） | 2026-04-22 | Chinese | ||
| 41177416 | 会计师事务所对公司控股股东及其他关联方占用资金情况的专项说明 | 2026-04-22 | Chinese | ||
| 41177414 | 康恩贝2025年度会计师事务所履职情况评估报告 | 2026-04-22 | Chinese | ||
| 41177411 | 关于计提2025年度资产减值准备的公告 | 2026-04-22 | Chinese | ||
| 41177408 | 关于2026年开展票据池业务的公告 | 2026-04-22 | Chinese | ||
| 41177407 | 康恩贝董事会关于独立董事独立性自查情况的专项报告 | 2026-04-22 | Chinese | ||
| 41177402 | 会计师对公司2025年年度审计报告 | 2026-04-22 | Chinese | ||
| 41177398 | 关于续聘会计师事务所的公告 | 2026-04-22 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Zhejiang CONBA Pharmaceutical Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56827/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56827 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56827 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56827 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56827}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Zhejiang CONBA Pharmaceutical Co.,Ltd. (id: 56827)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.